Cecelia Miller

The Ohio State University Wexner Medical Center — United States

Medicine · Health Sciences

12h-index471citations66works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(38), Lymphoma Diagnosis and Treatment(17), Immunodeficiency and Autoimmune Disorders(14), Acute Myeloid Leukemia Research(9), Cancer Genomics and Diagnostics(7)

Publications66 total

Optimizing bioinformatic workflows to extract clinically usable gene expression data from targeted RNA sequencing panels: comparison with total RNAseq
2026Open Access
Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN–Associated and Sporadic <i>NF2</i> -Deficient Meningiomas
Cancer Research Communications·2025Open Access
Loss of the Y chromosome defines a biologically distinct subtype of Acute Myeloid Leukemia (AML), associated with decreased inflammatory response patterns, and favorable outcomes in young male patients (pts)
Blood·2025
Concurrent loss of TP53 and CDKN2A with tetraploidy predicts richter transformation and poor prognosis in chronic lymphocytic leukemia
Blood·2025Open Access
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study
Leukemia·2025· 1 citedOpen Access
Multicancer Detection Tests for Screening
Annals of Internal Medicine·2025· 6 cited
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study
Journal of Hematology & Oncology·2025· 1 citedOpen Access
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era
American Journal of Hematology·2025· 1 citedOpen Access
Incorporating automation in a cytogenetics laboratory: three practitioners’ perspectives on benefits and limitations
Molecular Cytogenetics·2025Open Access
Blood-Based Tests for Multiple Cancer Screening: A Systematic Review
2025· 2 cited
Novel Recurrent Cytogenetic Abnormalities Predict Overall Survival in Tetraploid/Near-Tetraploid Myelodysplastic Syndrome and Acute Myeloid Leukemia
Cancers·2025Open Access
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
Blood Cancer Journal·2025· 11 citedOpen Access
2: Artificial intelligence-assisted conventional chromosome analysis to explore clonal dynamics in chronic lymphocytic leukemia
Genetics in Medicine Open·2025· 1 citedOpen Access
3: Comparing and contrasting karyotype scoring guidelines for evaluating complex karyotype in chronic lymphocytic leukemia
Genetics in Medicine Open·2025Open Access
CRISPR-Cas9-Mediated Correction of <i>TSC2</i> Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 2
The CRISPR Journal·2024· 3 cited
A Multi-Center Retrospective Study on Complex Karyotype in Patients with Richter Transformation Who Received No Chemoimmunotherapy for Their CLL
Blood·2024
A Rapid Diagnostic Assay to Detect a DNA Methylation Signature of Menin Inhibitor Response in Acute Myeloid Leukemia
Blood·2024Open Access
Hodgkin Lymphoma Transformation in Patients Who Received No Prior Chemotherapy for CLL/SLL: Outcomes from a Multicenter Retrospective Study in the Modern Era of Therapy
Blood·2024
Outcomes of Patients with Chronic Lymphocytic Leukemia Discontinuing Bruton Tyrosine Kinase Inhibitors Due to Adverse Effects
Blood·2024· 1 cited
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
Journal of Clinical Oncology·2024· 41 cited
page 1 of 4Next →

Frequent Co-authors

Jennifer A. Woyach(25), Kerry A. Rogers(23), Adam S. Kittai(18), Seema A. Bhat(18), Michael R. Grever(18), Nyla A. Heerema(18), Ying Huang(15), Amy S. Ruppert(14), John C. Byrd(14), John C. Byrd(13), Matthew R. Avenarius(12), Gerard Lozanski(11), Lynne V. Abruzzo(11), James S. Blachly(9), David A. Bond(8), Weiqiang Zhao(8), Erin Hertlein(6), Jadwiga Labanowska(6), Deborah M. Stephens(6), Danielle M. Brander(5)